Related Experiment Videos
The challenge of managing multiple cardiovascular risk factors
1University of Texas Southwestern Medical Center, Dallas 75235-8899, USA.
Insights
Hypertension management requires addressing all cardiovascular risks. Lifestyle changes and careful drug selection, like ACE inhibitors and calcium antagonists, are key to improving patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Preventive Medicine
Background:
- Hypertensive patients often present with multiple cardiovascular risk factors.
- Traditional treatments like diuretics and beta-blockers can negatively impact metabolic risk factors such as lipids and insulin sensitivity.
Purpose of the Study:
- To emphasize the importance of identifying and managing all cardiovascular risk factors in hypertensive patients.
- To evaluate the influence of different antihypertensive drug classes on cardiovascular risk factors.
Main Methods:
- Review of existing literature on hypertension management and cardiovascular risk factors.
- Analysis of the metabolic effects of various antihypertensive drug classes (diuretics, beta-blockers, alpha-blockers, ACE inhibitors, calcium antagonists).
Main Results:
- Lifestyle modifications (smoking cessation, weight reduction, dietary changes, exercise) are crucial.
- Diuretics and beta-blockers may worsen lipid profiles and insulin sensitivity.
- Alpha-blockers and ACE inhibitors show potential benefits for metabolic indices.
- Calcium antagonists are generally metabolically neutral.
- Combination therapy, particularly low-dose ACE inhibitors with calcium antagonists, offers advantages.
Conclusions:
- Comprehensive management of hypertension involves addressing all cardiovascular risks through lifestyle changes and judicious drug selection.
- Combination therapy with ACE inhibitors and calcium antagonists is a promising strategy for both blood pressure control and risk factor amelioration.
Abstract:
Hypertensive patients have an excess of other cardiovascular risk factors. Moreover, traditional therapy based on diuretics and beta-blockers may aggravate these risk factors. Therefore, attention must be given to the identification of all pertinent risk factors and their amelioration by appropriate therapy. Such therapy must include lifestyle changes including cessation of smoking, reduction of obesity, moderation of sodium intake and alcohol consumption, and increased physical activity. When antihypertensive drugs are chosen, consideration should be given to their potential influences, either negative or positive, on other cardiovascular risk factors. In particular, the adverse effects of diuretics and beta-blockers on lipids and insulin sensitivity may preclude their use. alpha-Blockers and ACE inhibitors may have beneficial effects on these metabolic indices. Calcium antagonists are neutral in most regards. Whatever agents are chosen, the use of low doses in combination is being increasingly recognized as a better way to achieve the desired antihypertensive efficacy while minimizing adverse effects. As has been noted in the other papers in this supplement, the combination of an ACE inhibitor and a calcium antagonist is particularly attractive, not only to treat hypertension, but also to ameliorate other cardiovascular risk factors.